Cetuximab in combination with chemoradiation after induction chemotherapy of locoregionally advanced nasopharyngeal carcinoma: preliminary results

By He Xia   Xu Jianhua   Guo Wenjie   Jiang Xuesong   Wang Xue   Zong Dan  

Future Oncology, Vol. 9, Iss. 10, 2013-10 ,pp. : 1459-1467

Future Medicine

Access to resources Recommend Favorite

Cetuximab: Its Use in Combination with Radiation Therapy and Chemotherapy in the Multimodality Treatment of Head and Neck Cancer

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 3, Iss. 2, 2008-06 ,pp. : 76-83

Bentham Science Publishers

Access to resources Recommend Favorite

Efficacy of combination chemotherapy using a novel oral chemotherapeutic agent, TAS-102, together with bevacizumab, cetuximab, or panitumumab on human colorectal cancer xenografts

By                  

Oncology Reports, Vol. 33, Iss. 5, 2015-01 ,pp. : 2135-2142

Spandidos Publications

Access to resources Recommend Favorite

The outcome of advanced soft tissue sarcoma patients with complete tumour regression after either chemotherapy alone or chemotherapy plus surgery. The Scandinavian sarcoma group experience

By Wiklund T.   Saeter G.   Strander H.   Alvegard T.   Blomqvist C.  

European Journal of Cancer, Vol. 33, Iss. 3, 1997-03 ,pp. : 357-361

Elsevier

Access to resources Recommend Favorite

Characterisation of Complete Responders to Combination Chemotherapy for Advanced Breast Cancer: A Retrospective EORTC Breast Group Study

By Tomiak E.   Piccart M.   Mignolet F.   Sahmoud T.   Paridaens R.   Nooy M.   Beex L.   Fentiman I.S.   Muller A.   van der Schueren E.   Rubens R.D.  

European Journal of Cancer, Vol. 32, Iss. 11, 1996-10 ,pp. : 1876-1887

Elsevier

Access to resources Recommend Favorite